Hologic to acquire Fischer Imaging mammography assets:
This article was originally published in Clinica
Executive Summary
Women's health imaging firm Hologic has agreed to acquire Fischer Imaging's intellectual property in the field of mammography. The Bedford, Massachusetts-based acquirer will pay $32m in cash for technology including Fischer Imaging's SenoScan digital mammography and MammoTest stereotactic breast biopsy system. Cash-strapped Fischer Imaging, which settled litigation over mammography technology with Hologic in 2002, admitted in May that there was substantial doubt over whether it could continue as a going concern. It has struggled to bring SenoScan up to the standard needed to establish a position in the emerging digital mammography market.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.